• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年不明原因发热伴消耗综合征:两例 VEXAS 综合征伴炎症小体失调。

Unexplained fever with consumptive syndrome in the elderly: two cases of VEXAS syndrome with inflammasome dysregulation.

机构信息

Divisão de Imunologia Clínica e Alergia do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (USP), São Paulo, Brazil.

Divisão de Imunologia Clínica e Alergia, Centro de Doenças Raras e da Imunidade, Rede DASA - Hospital Nove de Julho, São Paulo, Brazil.

出版信息

Clin Exp Immunol. 2024 Oct 16;218(2):213-220. doi: 10.1093/cei/uxae069.

DOI:10.1093/cei/uxae069
PMID:39119941
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11482498/
Abstract

The aim of this study is to investigate the inflammasome dysregulation in peripheral blood leukocytes of VEXAS patients. The constitutive and in vitro triggered activation of inflammasome in PBMC and neutrophils was analyzed in two Brazilian patients with typical UBA1 mutations, and compared with healthy donors. Our findings highlight the constitutive activation of caspase-1 in VEXAS leukocytes, accompanied by increased plasma levels of IL-18. Furthermore, upon stimulation of isolated peripheral blood mononuclear cells (PBMC) and neutrophils, we observed not only the exhaustion of NLRP3 and NLRP1/CARD8 pathways in VEXAS PBMC but also a significant increase in NLRP3-mediated NETs release in VEXAS neutrophils. These findings support previous studies on the contribution of the inflammasome to VEXAS pathogenesis, identifying at least two profoundly affected pathways (NLRP3 and NLRP1/CARD8) in VEXAS peripheral blood.

摘要

本研究旨在探讨 VEXAS 患者外周血白细胞中炎症小体的失调。分析了两名具有典型 UBA1 突变的巴西患者和健康供体的 PBMC 和中性粒细胞中炎症小体的组成性和体外触发激活情况。我们的研究结果强调了 VEXAS 白细胞中 caspase-1 的组成性激活,同时伴有 IL-18 血浆水平升高。此外,在刺激分离的外周血单核细胞(PBMC)和中性粒细胞时,我们不仅观察到 VEXAS PBMC 中 NLRP3 和 NLRP1/CARD8 途径的衰竭,而且观察到 VEXAS 中性粒细胞中 NLRP3 介导的 NETs 释放显著增加。这些发现支持了先前关于炎症小体对 VEXAS 发病机制的贡献的研究,确定了至少两种在 VEXAS 外周血中受到严重影响的途径(NLRP3 和 NLRP1/CARD8)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e44d/11482498/d03d6d216350/uxae069_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e44d/11482498/d03d6d216350/uxae069_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e44d/11482498/d03d6d216350/uxae069_fig3.jpg

相似文献

1
Unexplained fever with consumptive syndrome in the elderly: two cases of VEXAS syndrome with inflammasome dysregulation.老年不明原因发热伴消耗综合征:两例 VEXAS 综合征伴炎症小体失调。
Clin Exp Immunol. 2024 Oct 16;218(2):213-220. doi: 10.1093/cei/uxae069.
2
The non-structural protein of SFTSV activates NLRP1 and CARD8 inflammasome through disrupting the DPP9-mediated ternary complex.发热伴血小板减少综合征病毒的非结构蛋白通过破坏DPP9介导的三元复合物激活NLRP1和CARD8炎性小体。
PLoS Pathog. 2025 Jul 3;21(7):e1013258. doi: 10.1371/journal.ppat.1013258. eCollection 2025 Jul.
3
Mechanistic insights from inflammasome structures.从炎症小体结构中获得的机制见解。
Nat Rev Immunol. 2024 Jul;24(7):518-535. doi: 10.1038/s41577-024-00995-w. Epub 2024 Feb 19.
4
Bystander monocytic cells drive infection-independent NLRP3 inflammasome response to SARS-CoV-2.旁观者单核细胞驱动 SARS-CoV-2 感染非依赖性 NLRP3 炎症小体反应。
mBio. 2024 Oct 16;15(10):e0081024. doi: 10.1128/mbio.00810-24. Epub 2024 Sep 6.
5
Bone Marrow Vacuolization at the Crossroads of Specialties: Molecular Insights and Diagnostic Challenges.专业交叉领域的骨髓空泡化:分子见解与诊断挑战
Eur J Haematol. 2025 Sep;115(3):204-217. doi: 10.1111/ejh.14441. Epub 2025 May 29.
6
Polymorphisms and expression of inflammasome genes are associated with the development and severity of rheumatoid arthritis in Brazilian patients.炎症小体基因的多态性和表达与巴西患者类风湿关节炎的发生发展及严重程度相关。
Inflamm Res. 2018 Mar;67(3):255-264. doi: 10.1007/s00011-017-1119-2. Epub 2017 Dec 11.
7
p62 mRNA suppresses NLRP1 expression in cutaneous SCC cells through miR-34a-5p.p62信使核糖核酸通过微小核糖核酸-34a-5p抑制皮肤鳞状细胞癌细胞中NLRP1的表达。
Cell Death Dis. 2025 Jul 1;16(1):465. doi: 10.1038/s41419-025-07785-9.
8
[Mechanism of Yishen Jiangtang Decoction in regulating endoplasmic reticulum stress-mediated NLRP3 inflammasome to improve renal damage in diabetic nephropathy db/db mice].益肾降糖汤调控内质网应激介导的NLRP3炎性小体改善糖尿病肾病db/db小鼠肾损伤的机制
Zhongguo Zhong Yao Za Zhi. 2025 May;50(10):2740-2749. doi: 10.19540/j.cnki.cjcmm.20250114.401.
9
Increased expression of ER stress, inflammasome activation, and mitochondrial biogenesis-related genes in peripheral blood mononuclear cells in major depressive disorder.重度抑郁症患者外周血单个核细胞中内质网应激、炎性小体激活及线粒体生物合成相关基因的表达增加。
Mol Psychiatry. 2025 Feb;30(2):574-586. doi: 10.1038/s41380-024-02695-2. Epub 2024 Aug 22.
10
Two-pore potassium channel TREK-1 (K2P2.1) regulates NLRP3 inflammasome activity in macrophages.双孔钾通道 TREK-1(K2P2.1)调节巨噬细胞中的 NLRP3 炎性小体活性。
Am J Physiol Lung Cell Mol Physiol. 2024 Mar 1;326(3):L367-L376. doi: 10.1152/ajplung.00313.2023. Epub 2024 Jan 22.

本文引用的文献

1
Allogeneic hematopoietic cell transplantation for VEXAS syndrome: results of a multicenter study of the EBMT.异基因造血细胞移植治疗VEXAS综合征:欧洲血液与骨髓移植协会多中心研究结果
Blood Adv. 2024 Mar 26;8(6):1444-1448. doi: 10.1182/bloodadvances.2023012478.
2
VEXAS syndrome is characterized by inflammasome activation and monocyte dysregulation.VEXAS 综合征的特征为炎性体激活和单核细胞失调。
Nat Commun. 2024 Jan 30;15(1):910. doi: 10.1038/s41467-024-44811-4.
3
Serious infections in patients with VEXAS syndrome: data from the French VEXAS registry.
VEXAS 综合征患者的严重感染:法国 VEXAS 登记处的数据。
Ann Rheum Dis. 2024 Feb 15;83(3):372-381. doi: 10.1136/ard-2023-224819.
4
How to treat VEXAS syndrome: a systematic review on effectiveness and safety of current treatment strategies.如何治疗 VEXAS 综合征:当前治疗策略的有效性和安全性的系统评价。
Rheumatology (Oxford). 2023 Nov 2;62(11):3518-3525. doi: 10.1093/rheumatology/kead240.
5
Accurate stratification between VEXAS syndrome and differential diagnoses by deep learning analysis of peripheral blood smears.通过外周血涂片深度学习分析对 VEXAS 综合征与鉴别诊断进行准确分层。
Clin Chem Lab Med. 2023 Feb 2;61(7):1275-1279. doi: 10.1515/cclm-2022-1283. Print 2023 Jun 27.
6
Estimated Prevalence and Clinical Manifestations of UBA1 Variants Associated With VEXAS Syndrome in a Clinical Population.在临床人群中与 VEXAS 综合征相关的 UBA1 变异体的估计患病率和临床表现。
JAMA. 2023 Jan 24;329(4):318-324. doi: 10.1001/jama.2022.24836.
7
Severe COVID-19 patients show a dysregulation of the NLRP3 inflammasome in circulating neutrophils.重症新冠病毒肺炎患者循环中性粒细胞中的NLRP3炎性小体出现失调。
Scand J Immunol. 2023 Mar;97(3):e13247. doi: 10.1111/sji.13247. Epub 2022 Dec 30.
8
An update on VEXAS syndrome.VEXAS综合征的最新情况。
Expert Rev Clin Immunol. 2023 Feb;19(2):203-215. doi: 10.1080/1744666X.2023.2157262. Epub 2022 Dec 26.
9
VEXAS Syndrome-A Review of Pathophysiology, Presentation, and Prognosis.VEXAS 综合征——发病机制、临床表现和预后的综述。
J Clin Rheumatol. 2023 Sep 1;29(6):298-306. doi: 10.1097/RHU.0000000000001905. Epub 2022 Oct 17.
10
Specific NLRP3 Inflammasome Assembling and Regulation in Neutrophils: Relevance in Inflammatory and Infectious Diseases.中性粒细胞中特定的 NLRP3 炎性小体的组装和调控:在炎症和感染性疾病中的相关性。
Cells. 2022 Apr 1;11(7):1188. doi: 10.3390/cells11071188.